GITR
Cambridge, Massachusetts, United States
About GITR
GITR develops therapies to enhance the immune system by enabling T cells to be more effective in attacking cancer cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.8M
- Last round: Series Unknown (May 2015)
- Phone: +1 617-252-4343
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/gitr-2505208 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.